R-Biopharm
R-Biopharm AG is a German biotech company developing diagnostic test kits, reagents, and mobile-analysis software for clinical diagnostics, food and feed safety, and nutrition care, serving B2B customers across 140+ countries via direct webshop, distributors, and subsidiaries.
- Company typePrivate
- Founded1988
- HeadquartersDarmstadt, Germany
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What R-Biopharm does
R-Biopharm AG is a privately held German biotechnology company founded in 1988, headquartered in Darmstadt with corporate seat in Pfungstadt. The company develops diagnostic test solutions across three divisions: Clinical Diagnostics (multiplex molecular biology assays via AusDiagnostics, immunoassays), Food & Feed Analysis (lateral flow tests such as RIDA®QUICK for mycotoxin and allergen detection, ELISA kits, microbiological and GMO testing), and Nutrition Care (programs for wellbeing, prevention, and therapy via nutrition-care.de). Underlying technology spans ELISA immunoassays, lateral flow immunochromatography, multiplex molecular diagnostics, and the RIDA®SMART APP, a smartphone-based computer vision tool using a patented algorithm to quantify lateral flow test results in the field.
R-Biopharm serves a strictly B2B customer base — the company explicitly states it does not supply consumers — through a sales-led motion combining a direct e-commerce webshop (shop.r-biopharm.com), authorized distributors registered via a portal, and regional subsidiaries including R-Biopharm Rhône Ltd. in Scotland, which develops and manufactures test kits and has achieved PAS 2060:2014 carbon neutrality verified by BSI. The product portfolio exceeds 500 SKUs distributed across 140+ countries; equipment rental is tied exclusively to R-Biopharm consumables, and software requires license-key registration with internet verification.
Revenue is generated through one-time product sales (kits, reagents), recurring equipment rental/loan, software licensing, and professional services including sample testing and technical support. Pricing is not publicly disclosed; orders operate on 30-day payment terms, with regional shipping thresholds. The company is family-controlled (CEO Christian Dreher, Supervisory Board Chairman Dr. Ralf M. Dreher), ISO 9001 and ISO 13485 certified, and pursues ISO 14001 environmental management certification at headquarters.
R-Biopharm firmographics
Firmographics- Name
- R-Biopharm
- Legal name
- R-Biopharm AG
- Website
- https://r-biopharm.com
- Company type
- Private
- Founded year
- 1988
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- R-Biopharm AG is a German biotech company developing diagnostic test kits, reagents, and mobile-analysis software for clinical diagnostics, food and feed safety, and nutrition care, serving B2B customers across 140+ countries via direct webshop, distributors, and subsidiaries.
- Ownership category
- akta.pro rank
R-Biopharm industry classification
Industry- Product category
- Clinical Diagnostics
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Food, Feed & Nutraceutical Analytical Testing (HLAGADAN)
- akta.pro secondary industries
- Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices) (AFALAEAK), Proficiency Testing, Method Validation & Reference Materials (Food Labs) (AFALAAAK), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)
Keywords
Where R-Biopharm is headquartered
LocationHeadquarters
- HQ city
- Darmstadt
- HQ country
- Germany
- HQ region
- Europe
Offices3 records
Markets served
R-Biopharm business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Diagnostic and Testing Products: Sale of test kits, reagents, and diagnostic products for clinical diagnostics and food/feed analysis. Products include RIDA®QUICK lateral flow tests, ELISA kits, and related consumables. Orders placed via webshop, mail, phone, or email with payment terms of 30 days.
- Laboratory Equipment Rental and Loan: Rental and loan of laboratory equipment subject to supplemental terms (Rental and Loan Conditions). Equipment provided exclusively for use with R-Biopharm products.
- Software Licenses and SaaS: Software products including RIDA®SMART APP with license key registration and internet connection requirement for license verification. Software support services vary by product and business relationship.
- Professional Services: Services including sample testing, claim assessment, device maintenance, and technical support. Subject to separate General Service Conditions.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Standard product pricing through webshop or price list |
| Subscription | Monthly | Rental and loan of laboratory equipment |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels8 records
R-Biopharm product offering
Product offeringCore offering
R-Biopharm develops, manufactures, and sells diagnostic test kits, reagents, and analytical instruments for clinical diagnostics and food/feed safety testing. Core products include RIDA®QUICK lateral flow tests for mycotoxin detection, ELISA kits for proteins and allergens, the RIDA®SMART APP for smartphone-based test evaluation, and AusDiagnostics multiplex molecular diagnostics. The company also offers laboratory equipment, consumables, and professional services such as sample testing and technical support.
Differentiator
Problem solved
Functional benefit
Brands
- RIDA®SMART APP: A digital application for the quantification of RIDA®QUICK Mycotoxin Lateral Flow Tests, enabling fast and reliable quality control for mycotoxin contamination detection in food, feed, and raw materials.
- Clinical Diagnostics
- Food & Feed Analysis
- Nutrition Care
Products and services
- RIDA®QUICK Lateral Flow Tests Rapid lateral flow immunoassay kits designed for the qualitative and quantitative detection of mycotoxins in food and feed samples; intended for use by food and feed quality control laboratories and on-site operators, often paired with the RIDA®SMART APP for smartphone-based readout.
- ELISA Test Kits Enzyme-linked immunosorbent assay kits for the detection of proteins, allergens, mycotoxins, hormones, antibiotics, and other analytes in food, feed, and clinical samples; targeted at commercial testing laboratories and clinical labs performing routine batch analysis.
- RIDA®SMART APP Smartphone application using a patented algorithm to evaluate RIDA®QUICK lateral flow tests, providing quantitative results without specialized laboratory readers; for food and feed producers, processors, and field inspectors performing on-site mycotoxin screening.
- AusDiagnostics Multiplex Molecular Diagnostics Platform Multiplex molecular diagnostic assays and instruments (via subsidiary AusDiagnostics) enabling simultaneous detection of multiple pathogens or targets in clinical and applied diagnostics; for hospital and reference laboratories running high-throughput molecular testing.
- Laboratory Equipment (incl. rental/loan) Laboratory instruments, readers, and consumables available for purchase or rental/loan to support R-Biopharm's immunoassay and molecular diagnostic workflows; intended for commercial and clinical laboratory customers.
- Professional Services (Sample Testing & Technical Support) Analytical services and technical support including sample testing and customer technical assistance; offered to food/feed producers, processors, and clinical laboratory customers using or evaluating R-Biopharm diagnostic products.
Quantifiable outcome
- Reduced carbon footprint by approximately 29% in 2022 through renewable electricity and energy-saving initiatives
- +1 more outcomes
Companies that use R-Biopharm
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
R-Biopharm technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability3 records
Feature4 records
R-Biopharm partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and minor.
- AusDiagnosticscoreR-Biopharm AG acquired Australian molecular biology diagnostics company AusDiagnostics in June 2022. The acquisition expands R-Biopharm's product portfolio and market presence in clinical diagnostics, leveraging AusDiagnostics' multiplex analysis platform used globally in hospitals and laboratories. The deal strengthens R-Biopharm's position as a provider of system solutions in laboratory diagnostics.
- Custom MedicalminorR-Biopharm collaborated with experts from Custom Medical in Darmstadt to analyze user needs, examine pain points during use, and jointly optimize the user experience for the RIDA®SMART APP rapid mycotoxin analysis solution.
- LORICA GmbHminorLORICA GmbH (Pfotenhauerstr. 63, 01307 Dresden) operates the whistleblowing reporting system on behalf of R-Biopharm AG. LORICA acts as a processor for R-Biopharm AG, handling investigation of reported matters and follow-up actions.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
R-Biopharm competitors and assessment
Company assessmentDirect peers
- Bio-Rad Laboratories: Bio-Rad is a global clinical diagnostics and life science research company offering a broad test kit and reagent portfolio (including food safety pathogen testing) that directly competes with R-Biopharm's clinical diagnostics and food/feed analysis product lines.
- Romer Labs: Romer Labs specializes in mycotoxin, allergen, and food safety diagnostic test kits and reference materials. It is a focused, direct competitor to R-Biopharm in the mycotoxin and food/feed analysis segment, including lateral flow and ELISA formats.
- Hygiena: Hygiena provides rapid food safety and environmental hygiene diagnostic tests, including ATP and molecular pathogen detection. It competes with R-Biopharm's food/feed analysis product line in rapid on-site and laboratory food safety testing.
- bioMérieux: bioMérieux is a leading in vitro diagnostics and microbiology company serving both clinical diagnostics and industrial microbiology (including food safety). Its immunoassay, molecular, and culture-based food pathogen testing directly overlap with R-Biopharm's lateral flow, ELISA, and molecular offerings.
- Neogen Corporation: Neogen is a pure-play food safety and animal safety diagnostics company offering lateral flow, ELISA, and molecular test kits for mycotoxins, allergens, and pathogens—directly comparable to R-Biopharm's Food & Feed Analysis portfolio, including mycotoxin testing.
Broad incumbents
- Bureau Veritas: Bureau Veritas is a global TIC company with significant agri-food and commodity testing operations. It is a broad incumbent that competes with R-Biopharm for food and feed safety testing demand from producers, traders, and regulators worldwide.
- SGS (Société Générale de Surveillance): SGS is one of the world's largest testing, inspection, and certification companies with a major food and agricultural testing business. As a broad incumbent TIC provider, it competes with R-Biopharm in the food/feed safety value chain, particularly through contracted laboratory services.
- Eurofins Scientific: Eurofins is the world's largest food testing services network and also offers diagnostic test kits, making it a broad incumbent competitor. While R-Biopharm is more product-focused, both compete for food/feed safety testing spend from the same end-customers (food producers, feed mills, regulators).
- Charles River Laboratories: Charles River provides laboratory and diagnostic services across life sciences, food safety, and clinical research. It is a broad incumbent serving overlapping end-markets (food, feed, clinical) with bundled testing and product offerings adjacent to R-Biopharm's portfolio.
- Euroimmun (Revvity/PerkinElmer): Euroimmun is a leading European autoimmune and infectious disease diagnostics company, now part of Revvity (formerly PerkinElmer). Its specialty IVD and immunoassay portfolio competes with R-Biopharm's clinical diagnostics division, including the AusDiagnostics multiplex platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
R-Biopharm social profiles
Digital presenceR-Biopharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
R-Biopharm leadership team
Management profileNumber of profiles
Profiles6 records
R-Biopharm subsidiaries and ownership
Company hierarchySubsidiaries2 records
R-Biopharm funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
R-Biopharm M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about R-Biopharm
What does R-Biopharm do?
R-Biopharm develops, manufactures, and sells diagnostic test kits, reagents, and analytical instruments for clinical diagnostics and food/feed safety testing. Core products include RIDA®QUICK lateral flow tests for mycotoxin detection, ELISA kits for proteins and allergens, the RIDA®SMART APP for smartphone-based test evaluation, and AusDiagnostics multiplex molecular diagnostics. The company also offers laboratory equipment, consumables, and professional services such as sample testing and technical support.
Is R-Biopharm a public or private company?
R-Biopharm is a private company. It is classified as family owned and is currently operating.
When was R-Biopharm founded?
R-Biopharm was founded in 1988. It employs 1,001 to 5,000 people.
Where is R-Biopharm based?
R-Biopharm is headquartered in Darmstadt, Germany, in the Europe region.
How does R-Biopharm make money?
Four revenue lines are on record. Diagnostic and Testing Products are the primary driver. The others are laboratory Equipment Rental and Loan, software Licenses and SaaS and professional Services.
Who are R-Biopharm's main competitors?
Direct peers on record are Bio-Rad Laboratories, Romer Labs, Hygiena, bioMérieux and Neogen Corporation. Broad incumbents are Bureau Veritas, SGS (Société Générale de Surveillance), Eurofins Scientific, Charles River Laboratories and Euroimmun (Revvity/PerkinElmer).
Does R-Biopharm have an API?
No public API is recorded for R-Biopharm.
What industry is R-Biopharm in?
R-Biopharm's product category is Clinical Diagnostics. Its primary akta.pro industry code is HLAGADAN, Food, Feed & Nutraceutical Analytical Testing, with a secondary code of AFALAEAK, Rapid On-Site Environmental Testing Kits & Instruments (Lateral Flow, PCR, ATP Devices). Its NAICS code is 325413 and its SIC code is 2835.